                         SEQUENCE LISTING

<110>  Emamian, Effat
 
<120>  MODIFIED PEPTIDES AND ASSOCIATED METHODS OF USE

<130>  ADN0002PCT

<160>  128

<210>  1
<211>  351
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (1)..(351)
<223>  Accession no.: NP_002721

<400>  1

Met Gly Asn Ala Ala Ala Ala Lys Lys Gly Ser Glu Gln Glu Ser Val 
1               5                   10                  15      


Lys Glu Phe Leu Ala Lys Ala Lys Glu Asp Phe Leu Lys Lys Trp Glu 
            20                  25                  30          


Ser Pro Ala Gln Asn Thr Ala His Leu Asp Gln Phe Glu Arg Ile Lys 
        35                  40                  45              


Thr Leu Gly Thr Gly Ser Phe Gly Arg Val Met Leu Val Lys His Lys 
    50                  55                  60                  


Glu Thr Gly Asn His Tyr Ala Met Lys Ile Leu Asp Lys Gln Lys Val 
65                  70                  75                  80  


Val Lys Leu Lys Gln Ile Glu His Thr Leu Asn Glu Lys Arg Ile Leu 
                85                  90                  95      


Gln Ala Val Asn Phe Pro Phe Leu Val Lys Leu Glu Phe Ser Phe Lys 
            100                 105                 110         


Asp Asn Ser Asn Leu Tyr Met Val Met Glu Tyr Val Pro Gly Gly Glu 
        115                 120                 125             


Met Phe Ser His Leu Arg Arg Ile Gly Arg Phe Ser Glu Pro His Ala 
    130                 135                 140                 


Arg Phe Tyr Ala Ala Gln Ile Val Leu Thr Phe Glu Tyr Leu His Ser 
145                 150                 155                 160 


Leu Asp Leu Ile Tyr Arg Asp Leu Lys Pro Glu Asn Leu Leu Ile Asp 
                165                 170                 175     


Gln Gln Gly Tyr Ile Gln Val Thr Asp Phe Gly Phe Ala Lys Arg Val 
            180                 185                 190         


Lys Gly Arg Thr Trp Thr Leu Cys Gly Thr Pro Glu Tyr Leu Ala Pro 
        195                 200                 205             


Glu Ile Ile Leu Ser Lys Gly Tyr Asn Lys Ala Val Asp Trp Trp Ala 
    210                 215                 220                 


Leu Gly Val Leu Ile Tyr Glu Met Ala Ala Gly Tyr Pro Pro Phe Phe 
225                 230                 235                 240 


Ala Asp Gln Pro Ile Gln Ile Tyr Glu Lys Ile Val Ser Gly Lys Val 
                245                 250                 255     


Arg Phe Pro Ser His Phe Ser Ser Asp Leu Lys Asp Leu Leu Arg Asn 
            260                 265                 270         


Leu Leu Gln Val Asp Leu Thr Lys Arg Phe Gly Asn Leu Lys Asn Gly 
        275                 280                 285             


Val Asn Asp Ile Lys Asn His Lys Trp Phe Ala Thr Thr Asp Trp Ile 
    290                 295                 300                 


Ala Ile Tyr Gln Arg Lys Val Glu Ala Pro Phe Ile Pro Lys Phe Lys 
305                 310                 315                 320 


Gly Pro Gly Asp Thr Ser Asn Phe Asp Asp Tyr Glu Glu Glu Glu Ile 
                325                 330                 335     


Arg Val Ser Ile Asn Glu Lys Cys Gly Lys Glu Phe Ser Glu Phe 
            340                 345                 350     


<210>  2
<211>  343
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (1)..(343)
<223>  Accession no.: NP_997401

<400>  2

Met Ala Ser Asn Ser Ser Asp Val Lys Glu Phe Leu Ala Lys Ala Lys 
1               5                   10                  15      


Glu Asp Phe Leu Lys Lys Trp Glu Ser Pro Ala Gln Asn Thr Ala His 
            20                  25                  30          


Leu Asp Gln Phe Glu Arg Ile Lys Thr Leu Gly Thr Gly Ser Phe Gly 
        35                  40                  45              


Arg Val Met Leu Val Lys His Lys Glu Thr Gly Asn His Tyr Ala Met 
    50                  55                  60                  


Lys Ile Leu Asp Lys Gln Lys Val Val Lys Leu Lys Gln Ile Glu His 
65                  70                  75                  80  


Thr Leu Asn Glu Lys Arg Ile Leu Gln Ala Val Asn Phe Pro Phe Leu 
                85                  90                  95      


Val Lys Leu Glu Phe Ser Phe Lys Asp Asn Ser Asn Leu Tyr Met Val 
            100                 105                 110         


Met Glu Tyr Val Pro Gly Gly Glu Met Phe Ser His Leu Arg Arg Ile 
        115                 120                 125             


Gly Arg Phe Ser Glu Pro His Ala Arg Phe Tyr Ala Ala Gln Ile Val 
    130                 135                 140                 


Leu Thr Phe Glu Tyr Leu His Ser Leu Asp Leu Ile Tyr Arg Asp Leu 
145                 150                 155                 160 


Lys Pro Glu Asn Leu Leu Ile Asp Gln Gln Gly Tyr Ile Gln Val Thr 
                165                 170                 175     


Asp Phe Gly Phe Ala Lys Arg Val Lys Gly Arg Thr Trp Thr Leu Cys 
            180                 185                 190         


Gly Thr Pro Glu Tyr Leu Ala Pro Glu Ile Ile Leu Ser Lys Gly Tyr 
        195                 200                 205             


Asn Lys Ala Val Asp Trp Trp Ala Leu Gly Val Leu Ile Tyr Glu Met 
    210                 215                 220                 


Ala Ala Gly Tyr Pro Pro Phe Phe Ala Asp Gln Pro Ile Gln Ile Tyr 
225                 230                 235                 240 


Glu Lys Ile Val Ser Gly Lys Val Arg Phe Pro Ser His Phe Ser Ser 
                245                 250                 255     


Asp Leu Lys Asp Leu Leu Arg Asn Leu Leu Gln Val Asp Leu Thr Lys 
            260                 265                 270         


Arg Phe Gly Asn Leu Lys Asn Gly Val Asn Asp Ile Lys Asn His Lys 
        275                 280                 285             


Trp Phe Ala Thr Thr Asp Trp Ile Ala Ile Tyr Gln Arg Lys Val Glu 
    290                 295                 300                 


Ala Pro Phe Ile Pro Lys Phe Lys Gly Pro Gly Asp Thr Ser Asn Phe 
305                 310                 315                 320 


Asp Asp Tyr Glu Glu Glu Glu Ile Arg Val Ser Ile Asn Glu Lys Cys 
                325                 330                 335     


Gly Lys Glu Phe Ser Glu Phe 
            340             


<210>  3
<211>  351
<212>  PRT
<213>  Bos taurus


<220>
<221>  MISC_FEATURE
<222>  (1)..(351)
<223>  Accession no.: CAA47627

<400>  3

Met Gly Asn Ala Ala Ala Ala Lys Lys Gly Ser Glu Gln Glu Ser Val 
1               5                   10                  15      


Lys Glu Phe Leu Ala Lys Ala Lys Glu Asp Phe Leu Lys Lys Trp Glu 
            20                  25                  30          


Asn Pro Ala Gln Asn Thr Ala His Leu Asp Gln Phe Glu Arg Ile Lys 
        35                  40                  45              


Thr Leu Gly Thr Gly Ser Phe Gly Arg Val Met Leu Val Lys His Met 
    50                  55                  60                  


Glu Thr Gly Asn His Tyr Ala Met Lys Ile Leu Asp Lys Gln Lys Val 
65                  70                  75                  80  


Val Lys Leu Lys Gln Ile Glu His Thr Leu Asn Glu Lys Arg Ile Leu 
                85                  90                  95      


Gln Ala Val Asn Phe Pro Phe Leu Val Lys Leu Glu Phe Ser Phe Lys 
            100                 105                 110         


Asp Asn Ser Asn Leu Tyr Met Val Met Glu Tyr Val Pro Gly Gly Glu 
        115                 120                 125             


Met Phe Ser His Leu Arg Arg Ile Gly Arg Phe Ser Glu Pro His Ala 
    130                 135                 140                 


Arg Phe Tyr Ala Ala Gln Ile Val Leu Thr Phe Glu Tyr Leu His Ser 
145                 150                 155                 160 


Leu Asp Leu Ile Tyr Arg Asp Leu Lys Pro Glu Asn Leu Leu Ile Asp 
                165                 170                 175     


Gln Gln Gly Tyr Ile Gln Val Thr Asp Phe Gly Phe Ala Lys Arg Val 
            180                 185                 190         


Lys Gly Arg Thr Trp Thr Leu Cys Gly Thr Pro Glu Tyr Leu Ala Pro 
        195                 200                 205             


Glu Ile Ile Leu Ser Lys Gly Tyr Asn Lys Ala Val Asp Trp Trp Ala 
    210                 215                 220                 


Leu Gly Val Leu Ile Tyr Glu Met Ala Ala Gly Tyr Pro Pro Phe Phe 
225                 230                 235                 240 


Ala Asp Gln Pro Ile Gln Ile Tyr Glu Lys Ile Val Ser Gly Lys Val 
                245                 250                 255     


Arg Phe Pro Ser His Phe Ser Ser Asp Leu Lys Asp Leu Leu Arg Asn 
            260                 265                 270         


Leu Leu Gln Val Asp Leu Thr Lys Arg Phe Gly Asn Leu Lys Asn Gly 
        275                 280                 285             


Val Asn Asp Ile Lys Asn His Lys Trp Phe Ala Thr Thr Asp Trp Ile 
    290                 295                 300                 


Ala Ile Tyr Gln Arg Lys Val Glu Ala Pro Phe Ile Pro Lys Phe Lys 
305                 310                 315                 320 


Gly Pro Gly Asp Thr Ser Asn Phe Asp Asp Tyr Glu Glu Glu Glu Ile 
                325                 330                 335     


Arg Val Ser Ile Asn Glu Lys Cys Gly Lys Glu Phe Ser Glu Phe 
            340                 345                 350     


<210>  4
<211>  350
<212>  PRT
<213>  Canis familiaris


<220>
<221>  MISC_FEATURE
<222>  (1)..(350)
<223>  Accession no.: NP_001003032

<400>  4

Met Gly Asn Ala Ala Ala Lys Lys Gly Ser Glu Gln Glu Ser Val Lys 
1               5                   10                  15      


Glu Phe Leu Ala Lys Ala Lys Glu Asp Phe Leu Lys Lys Trp Glu Asn 
            20                  25                  30          


Pro Ala Gln Asn Thr Ala His Leu Asp Gln Phe Glu Arg Ile Lys Thr 
        35                  40                  45              


Leu Gly Thr Gly Ser Phe Gly Arg Val Met Leu Val Lys His Lys Glu 
    50                  55                  60                  


Thr Gly Asn His Phe Ala Met Lys Ile Leu Asp Lys Gln Lys Val Val 
65                  70                  75                  80  


Lys Leu Lys Gln Ile Glu His Thr Leu Asn Glu Lys Arg Ile Leu Gln 
                85                  90                  95      


Ala Val Asn Phe Pro Phe Leu Val Lys Leu Glu Phe Ser Phe Lys Asp 
            100                 105                 110         


Asn Ser Asn Leu Tyr Met Val Met Glu Tyr Val Pro Gly Gly Glu Met 
        115                 120                 125             


Phe Ser His Leu Arg Arg Ile Gly Arg Phe Ser Glu Pro His Ala Arg 
    130                 135                 140                 


Phe Tyr Ala Ala Gln Ile Val Leu Thr Phe Glu Tyr Leu His Ser Leu 
145                 150                 155                 160 


Asp Leu Ile Tyr Arg Asp Leu Lys Pro Glu Asn Leu Leu Ile Asp Gln 
                165                 170                 175     


Gln Gly Tyr Ile Gln Val Thr Asp Phe Gly Phe Ala Lys Arg Val Lys 
            180                 185                 190         


Gly Arg Thr Trp Thr Leu Cys Gly Thr Pro Glu Tyr Leu Ala Pro Glu 
        195                 200                 205             


Ile Ile Leu Ser Lys Gly Tyr Asn Lys Ala Val Asp Trp Trp Ala Leu 
    210                 215                 220                 


Gly Val Leu Ile Tyr Glu Met Ala Ala Gly Tyr Pro Pro Phe Phe Ala 
225                 230                 235                 240 


Asp Gln Pro Ile Gln Ile Tyr Glu Lys Ile Val Ser Gly Lys Val Arg 
                245                 250                 255     


Phe Pro Ser His Phe Ser Ser Asp Leu Lys Asp Leu Leu Arg Asn Leu 
            260                 265                 270         


Leu Gln Val Asp Leu Thr Lys Arg Phe Gly Asn Leu Lys Asn Gly Val 
        275                 280                 285             


Asn Asp Ile Lys Asn His Lys Trp Phe Ala Thr Thr Asp Trp Ile Ala 
    290                 295                 300                 


Ile Tyr Gln Arg Lys Val Glu Ala Pro Phe Ile Pro Lys Phe Lys Gly 
305                 310                 315                 320 


Pro Gly Asp Thr Ser Asn Phe Asp Asp Tyr Glu Glu Glu Glu Ile Arg 
                325                 330                 335     


Val Ser Ile Asn Glu Lys Cys Gly Lys Glu Phe Cys Glu Phe 
            340                 345                 350 


<210>  5
<211>  351
<212>  PRT
<213>  Mus musculus


<220>
<221>  MISC_FEATURE
<222>  (1)..(351)
<223>  Accession no.: NP_032880

<400>  5

Met Gly Asn Ala Ala Ala Ala Lys Lys Gly Ser Glu Gln Glu Ser Val 
1               5                   10                  15      


Lys Glu Phe Leu Ala Lys Ala Lys Glu Asp Phe Leu Lys Lys Trp Glu 
            20                  25                  30          


Thr Pro Ser Gln Asn Thr Ala Gln Leu Asp Gln Phe Asp Arg Ile Lys 
        35                  40                  45              


Thr Leu Gly Thr Gly Ser Phe Gly Arg Val Met Leu Val Lys His Lys 
    50                  55                  60                  


Glu Ser Gly Asn His Tyr Ala Met Lys Ile Leu Asp Lys Gln Lys Val 
65                  70                  75                  80  


Val Lys Leu Lys Gln Ile Glu His Thr Leu Asn Glu Lys Arg Ile Leu 
                85                  90                  95      


Gln Ala Val Asn Phe Pro Phe Leu Val Lys Leu Glu Phe Ser Phe Lys 
            100                 105                 110         


Asp Asn Ser Asn Leu Tyr Met Val Met Glu Tyr Val Ala Gly Gly Glu 
        115                 120                 125             


Met Phe Ser His Leu Arg Arg Ile Gly Arg Phe Ser Glu Pro His Ala 
    130                 135                 140                 


Arg Phe Tyr Ala Ala Gln Ile Val Leu Thr Phe Glu Tyr Leu His Ser 
145                 150                 155                 160 


Leu Asp Leu Ile Tyr Arg Asp Leu Lys Pro Glu Asn Leu Leu Ile Asp 
                165                 170                 175     


Gln Gln Gly Tyr Ile Gln Val Thr Asp Phe Gly Phe Ala Lys Arg Val 
            180                 185                 190         


Lys Gly Arg Thr Trp Thr Leu Cys Gly Thr Pro Glu Tyr Leu Ala Pro 
        195                 200                 205             


Glu Ile Ile Leu Ser Lys Gly Tyr Asn Lys Ala Val Asp Trp Trp Ala 
    210                 215                 220                 


Leu Gly Val Leu Ile Tyr Glu Met Ala Ala Gly Tyr Pro Pro Phe Phe 
225                 230                 235                 240 


Ala Asp Gln Pro Ile Gln Ile Tyr Glu Lys Ile Val Ser Gly Lys Val 
                245                 250                 255     


Arg Phe Pro Ser His Phe Ser Ser Asp Leu Lys Asp Leu Leu Arg Asn 
            260                 265                 270         


Leu Leu Gln Val Asp Leu Thr Lys Arg Phe Gly Asn Leu Lys Asn Gly 
        275                 280                 285             


Val Asn Asp Ile Lys Asn His Lys Trp Phe Ala Thr Thr Asp Trp Ile 
    290                 295                 300                 


Ala Ile Tyr Gln Arg Lys Val Glu Ala Pro Phe Ile Pro Lys Phe Lys 
305                 310                 315                 320 


Gly Pro Gly Asp Thr Ser Asn Phe Asp Asp Tyr Glu Glu Glu Glu Ile 
                325                 330                 335     


Arg Val Ser Ile Asn Glu Lys Cys Gly Lys Glu Phe Thr Glu Phe 
            340                 345                 350     


<210>  6
<211>  351
<212>  PRT
<213>  Rattus norvegicus


<220>
<221>  MISC_FEATURE
<222>  (1)..(351)
<223>  Accession no.: P27791

<400>  6

Met Gly Asn Ala Ala Ala Ala Lys Lys Gly Ser Glu Gln Glu Ser Val 
1               5                   10                  15      


Lys Glu Phe Leu Ala Lys Ala Lys Glu Asp Phe Leu Lys Lys Trp Glu 
            20                  25                  30          


Asp Pro Ser Gln Asn Thr Ala Gln Leu Asp His Phe Asp Arg Ile Lys 
        35                  40                  45              


Thr Leu Gly Thr Gly Ser Phe Gly Arg Val Met Leu Val Lys His Lys 
    50                  55                  60                  


Glu Ser Gly Asn His Tyr Ala Met Lys Ile Leu Asp Lys Gln Lys Val 
65                  70                  75                  80  


Val Lys Leu Lys Gln Ile Glu His Thr Leu Asn Glu Lys Arg Ile Leu 
                85                  90                  95      


Gln Ala Val Asn Phe Pro Phe Leu Val Lys Leu Glu Phe Ser Phe Lys 
            100                 105                 110         


Asp Asn Ser Asn Leu Tyr Met Val Met Glu Tyr Val Pro Gly Gly Glu 
        115                 120                 125             


Met Phe Ser His Leu Arg Arg Ile Gly Arg Phe Ser Glu Pro His Ala 
    130                 135                 140                 


Arg Phe Tyr Ala Ala Gln Ile Val Leu Thr Phe Glu Tyr Leu His Ser 
145                 150                 155                 160 


Leu Asp Leu Ile Tyr Arg Asp Leu Lys Pro Glu Asn Leu Leu Ile Asp 
                165                 170                 175     


Gln Gln Gly Tyr Ile Gln Val Thr Asp Phe Gly Phe Ala Lys Arg Val 
            180                 185                 190         


Lys Gly Arg Thr Trp Thr Leu Cys Gly Thr Pro Glu Tyr Leu Ala Pro 
        195                 200                 205             


Glu Ile Ile Leu Ser Lys Gly Tyr Asn Lys Ala Val Asp Trp Trp Ala 
    210                 215                 220                 


Leu Gly Val Leu Ile Tyr Glu Met Ala Ala Gly Tyr Pro Pro Phe Phe 
225                 230                 235                 240 


Ala Asp Gln Pro Ile Gln Ile Tyr Glu Lys Ile Val Ser Gly Lys Val 
                245                 250                 255     


Arg Phe Pro Ser His Phe Ser Ser Asp Leu Lys Asp Leu Leu Arg Asn 
            260                 265                 270         


Leu Leu Gln Val Asp Leu Thr Lys Arg Phe Gly Asn Leu Lys Asn Gly 
        275                 280                 285             


Val Asn Asp Ile Lys Asn His Lys Trp Phe Ala Thr Thr Asp Trp Ile 
    290                 295                 300                 


Ala Ile Tyr Gln Arg Lys Val Glu Ala Pro Phe Ile Pro Lys Phe Lys 
305                 310                 315                 320 


Gly Pro Gly Asp Thr Ser Asn Phe Asp Asp Tyr Glu Glu Glu Glu Ile 
                325                 330                 335     


Arg Val Ser Ile Asn Glu Lys Cys Gly Lys Glu Phe Thr Glu Phe 
            340                 345                 350     


<210>  7
<211>  343
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic/consensus sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(343)
<223>  Consensus seq; PKA

<220>
<221>  MISC_FEATURE
<222>  (1)..(343)
<223>  Xaa can be any amino acid   

<400>  7

Xaa Xaa Ser Xaa Xaa Xaa Xaa Val Lys Glu Phe Leu Ala Lys Ala Lys 
1               5                   10                  15      


Glu Asp Phe Leu Lys Lys Trp Glu Xaa Pro Xaa Gln Asn Thr Ala Xaa 
            20                  25                  30          


Leu Asp Xaa Phe Xaa Arg Ile Lys Thr Leu Gly Thr Gly Ser Phe Gly 
        35                  40                  45              


Arg Val Met Leu Val Lys His Xaa Glu Thr Gly Asn His Xaa Ala Met 
    50                  55                  60                  


Lys Ile Leu Asp Lys Gln Lys Val Val Lys Leu Lys Gln Ile Glu His 
65                  70                  75                  80  


Thr Leu Asn Glu Lys Arg Ile Leu Gln Ala Val Asn Phe Pro Phe Leu 
                85                  90                  95      


Val Lys Leu Glu Phe Ser Phe Lys Asp Asn Ser Asn Leu Tyr Met Val 
            100                 105                 110         


Met Glu Tyr Val Pro Gly Gly Glu Met Phe Ser His Leu Arg Arg Ile 
        115                 120                 125             


Gly Arg Phe Ser Glu Pro His Ala Arg Phe Tyr Ala Ala Gln Ile Val 
    130                 135                 140                 


Leu Thr Phe Glu Tyr Leu His Ser Leu Asp Leu Ile Tyr Arg Asp Leu 
145                 150                 155                 160 


Lys Pro Glu Asn Leu Leu Ile Asp Gln Gln Gly Tyr Ile Gln Val Thr 
                165                 170                 175     


Asp Phe Gly Phe Ala Lys Arg Val Lys Gly Arg Thr Trp Thr Leu Cys 
            180                 185                 190         


Gly Thr Pro Glu Tyr Leu Ala Pro Glu Ile Ile Leu Ser Lys Gly Tyr 
        195                 200                 205             


Asn Lys Ala Val Asp Trp Trp Ala Leu Gly Val Leu Ile Tyr Glu Met 
    210                 215                 220                 


Ala Ala Gly Tyr Pro Pro Phe Phe Ala Asp Gln Pro Ile Gln Ile Tyr 
225                 230                 235                 240 


Glu Lys Ile Val Ser Gly Lys Val Arg Phe Pro Ser His Phe Ser Ser 
                245                 250                 255     


Asp Leu Lys Asp Leu Leu Arg Asn Leu Leu Gln Val Asp Leu Thr Lys 
            260                 265                 270         


Arg Phe Gly Asn Leu Lys Asn Gly Val Asn Asp Ile Lys Asn His Lys 
        275                 280                 285             


Trp Phe Ala Thr Thr Asp Trp Ile Ala Ile Tyr Gln Arg Lys Val Glu 
    290                 295                 300                 


Ala Pro Phe Ile Pro Lys Phe Lys Gly Pro Gly Asp Thr Ser Asn Phe 
305                 310                 315                 320 


Asp Asp Tyr Glu Glu Glu Glu Ile Arg Val Ser Ile Asn Glu Lys Cys 
                325                 330                 335     


Gly Lys Glu Phe Xaa Glu Phe 
            340             


<210>  8
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  Peptide_SEQ ID NO.8

<400>  8

Met Gly Asn Ala Ala Ala Ala Lys Lys Gly Ser Glu Gln Glu Ser Val 
1               5                   10                  15      


<210>  9
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:9

<400>  9

Ala Ala Lys Lys Gly Ser Glu Gln Glu Ser Val Lys Glu Phe Leu 
1               5                   10                  15  


<210>  10
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:10

<400>  10

Gly Ser Glu Gln Glu Ser Val Lys Glu Phe Leu Ala Lys Ala Lys 
1               5                   10                  15  


<210>  11
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:11

<400>  11

Glu Ser Val Lys Glu Phe Leu Ala Lys Ala Lys Glu Asp Phe Leu 
1               5                   10                  15  


<210>  12
<211>  14
<212>  PRT
<213>  Artificial sequence 

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:12

<400>  12

Glu Phe Leu Ala Lys Ala Lys Glu Asp Phe Leu Lys Lys Trp 
1               5                   10                  


<210>  13
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:13

<400>  13

Ala Lys Ala Lys Glu Asp Phe Leu Lys Lys Trp Glu Asn Pro Ala 
1               5                   10                  15  


<210>  14
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:14

<400>  14

Glu Asp Phe Leu Lys Lys Trp Glu Asn Pro Ala Gln Asn Thr Ala 
1               5                   10                  15  


<210>  15
<211>  13
<212>  PRT
<213>  Artificial sequence 

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  Peptide_SEQ ID NO:15

<400>  15

Lys Lys Trp Glu Asn Pro Ala Gln Asn Thr Ala His Leu 
1               5                   10              


<210>  16
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:16

<400>  16

Trp Glu Asn Pro Ala Gln Asn Thr Ala His Leu Asp Gln Phe 
1               5                   10                  


<210>  17
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:17

<400>  17

Pro Ala Gln Asn Thr Ala His Leu Asp Gln Phe Glu Arg Ile Lys 
1               5                   10                  15  


<210>  18
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  Peptide_SEQ ID NO:18

<400>  18

Thr Ala His Leu Asp Gln Phe Glu Arg Ile Lys Thr Leu 
1               5                   10              


<210>  19
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  Peptide_SEQ ID NO:19

<400>  19

His Leu Asp Gln Phe Glu Arg Ile Asp Thr Leu Gly Thr Gly Ser Phe 
1               5                   10                  15      


<210>  20
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:20

<400>  20

Glu Arg Ile Lys Thr Leu Gly Thr Gly Ser Phe Gly Arg Val Met 
1               5                   10                  15  


<210>  21
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:21

<400>  21

Thr Leu Gly Thr Gly Ser Phe Gly Arg Val Met Leu Val Lys His 
1               5                   10                  15  


<210>  22
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  Peptide_SEQ ID NO:22

<400>  22

Gly Ser Phe Gly Arg Val Met Leu Val Lys His Met 
1               5                   10          


<210>  23
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  Peptide_SEQ ID NO:23

<400>  23

Ser Phe Gly Arg Val Met Leu Val Lys His Met Glu Thr Gly Asn His 
1               5                   10                  15      


<210>  24
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:24

<400>  24

Met Leu Val Lys His Met Glu Thr Gly Asn His Tyr Ala Met Lys 
1               5                   10                  15  


<210>  25
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:25

<400>  25

His Met Glu Thr Gly Asn His Tyr Ala Met Lys Ile Leu Asp Lys 
1               5                   10                  15  


<210>  26
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:26

<400>  26

Gly Asn His Tyr Ala Met Lys Ile Leu Asp Lys Gln Lys Val Val 
1               5                   10                  15  


<210>  27
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:27

<400>  27

Ala Met Lys Ile Leu Asp Lys Gln Lys Val Val Lys Leu Lys 
1               5                   10                  


<210>  28
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:28

<400>  28

Ile Leu Asp Lys Gln Lys Val Val Lys Leu Lys Gln Ile Glu His 
1               5                   10                  15  


<210>  29
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:29

<400>  29

Lys Gln Lys Val Val Lys Leu Lys Gln Ile Glu His Thr Leu 
1               5                   10                  


<210>  30
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:30

<400>  30

Val Val Lys Leu Lys Gln Ile Glu His Thr Leu Asn Glu Lys Arg 
1               5                   10                  15  


<210>  31
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:31

<400>  31

Lys Gln Ile Glu His Thr Leu Asn Glu Lys Arg Ile Leu Gln Ala 
1               5                   10                  15  


<210>  32
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:32

<400>  32

His Thr Leu Asn Glu Lys Arg Ile Leu Gln Ala Val Asn Phe 
1               5                   10                  


<210>  33
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:33

<400>  33

Asn Glu Lys Arg Ile Leu Gln Ala Val Asn Phe Pro Phe Leu Val 
1               5                   10                  15  


<210>  34
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:34

<400>  34

Ile Leu Gln Ala Val Asn Phe Pro Phe Leu Val Lys Leu Glu Phe 
1               5                   10                  15  


<210>  35
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:35

<400>  35

Val Asn Phe Pro Phe Leu Val Lys Leu Glu Phe Ser Phe Lys 
1               5                   10                  


<210>  36
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  Peptide_SEQ ID NO:36

<400>  36

Pro Phe Leu Val Lys Leu Glu Phe Ser Phe Lys Asp Asn Ser Asn Leu 
1               5                   10                  15      


<210>  37
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:37

<400>  37

Leu Glu Phe Ser Phe Lys Asp Asn Ser Asn Leu Tyr Met Val Met 
1               5                   10                  15  


<210>  38
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:38

<400>  38

Phe Lys Asp Asn Ser Asn Leu Tyr Met Val Met Glu Tyr Val 
1               5                   10                  


<210>  39
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  Peptide_SEQ ID NO:39

<400>  39

Asn Ser Asn Leu Tyr Met Val Met Glu Tyr Val Pro Gly Gly Glu Met 
1               5                   10                  15      


<210>  40
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:40

<400>  40

Met Val Met Glu Tyr Val Pro Gly Gly Glu Met Phe Ser His Leu 
1               5                   10                  15  


<210>  41
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:41

<400>  41

Tyr Val Pro Gly Gly Glu Met Phe Ser His Leu Arg Arg Ile 
1               5                   10                  


<210>  42
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:42

<400>  42

Gly Gly Glu Met Phe Ser His Leu Arg Arg Ile Gly Arg Phe 
1               5                   10                  


<210>  43
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:43

<400>  43

Met Phe Ser His Leu Arg Arg Ile Gly Arg Phe Ser Glu Pro His 
1               5                   10                  15  


<210>  44
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:44

<400>  44

Leu Arg Arg Ile Gly Arg Phe Ser Glu Pro His Ala Arg Phe Tyr 
1               5                   10                  15  


<210>  45
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:45

<400>  45

Gly Arg Phe Ser Glu Pro His Ala Arg Phe Tyr Ala Ala Gln Ile 
1               5                   10                  15  


<210>  46
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:46

<400>  46

Glu Pro His Ala Arg Phe Tyr Ala Ala Gln Ile Val Leu Thr Phe 
1               5                   10                  15  


<210>  47
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:47

<400>  47

Arg Phe Tyr Ala Ala Gln Ile Val Leu Thr Phe Glu Tyr Leu His 
1               5                   10                  15  


<210>  48
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:48

<400>  48

Ala Gln Ile Val Leu Thr Phe Glu Tyr Leu His Ser Leu Asp Leu 
1               5                   10                  15  


<210>  49
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:49

<400>  49

Leu Thr Phe Glu Tyr Leu His Ser Leu Asp Leu Ile Tyr Arg 
1               5                   10                  


<210>  50
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:50

<400>  50

Glu Tyr Leu His Ser Leu Asp Leu Ile Tyr Arg Asp Leu Lys 
1               5                   10                  


<210>  51
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:51

<400>  51

His Ser Leu Asp Leu Ile Tyr Arg Asp Leu Lys Pro Glu Asn Leu 
1               5                   10                  15  


<210>  52
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  Peptide_SEQ ID NO:52

<400>  52

Leu Ile Tyr Arg Asp Leu Lys Pro Glu Asn Leu Leu Ile 
1               5                   10              


<210>  53
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  Peptide_SEQ ID NO:53

<400>  53

Tyr Arg Asp Leu Lys Pro Glu Asn Leu Leu Ile Asp Gln Gln Gly Tyr 
1               5                   10                  15      


<210>  54
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:54

<400>  54

Pro Glu Asn Leu Leu Ile Asp Gln Gln Gly Tyr Ile Gln Val 
1               5                   10                  


<210>  55
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:55

<400>  55

Leu Leu Ile Asp Gln Gln Gly Tyr Ile Gln Val Thr Asp Phe 
1               5                   10                  


<210>  56
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:56

<400>  56

Asp Gln Gln Gly Tyr Ile Gln Val Thr Asp Phe Gly Phe Ala Lys 
1               5                   10                  15  


<210>  57
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:57

<400>  57

Tyr Ile Gln Val Thr Asp Phe Gly Phe Ala Lys Arg Val Lys 
1               5                   10                  


<210>  58
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:58

<400>  58

Val Thr Asp Phe Gly Phe Ala Lys Arg Val Lys Gly Arg Thr Trp 
1               5                   10                  15  


<210>  59
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  Peptide_SEQ ID NO:59

<400>  59

Gly Phe Ala Lys Arg Val Lys Gly Arg Thr Trp Thr Leu 
1               5                   10              


<210>  60
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  Peptide_SEQ ID NO:60

<400>  60

Ala Lys Arg Val Lys Gly Arg Thr Trp Thr Leu Cys Gly Thr Pro Glu 
1               5                   10                  15      


Tyr 
    


<210>  61
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  Peptide_SEQ ID NO:61

<400>  61

Arg Thr Trp Thr Leu Cys Gly Thr Pro Glu Tyr Leu Ala 
1               5                   10              


<210>  62
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:62

<400>  62

Trp Thr Leu Cys Gly Thr Pro Glu Tyr Leu Ala Pro Glu Ile Ile 
1               5                   10                  15  


<210>  63
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:63

<400>  63

Gly Thr Pro Glu Tyr Leu Ala Pro Glu Ile Ile Leu Ser Lys 
1               5                   10                  


<210>  64
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:64

<400>  64

Glu Tyr Leu Ala Pro Glu Ile Ile Leu Ser Lys Gly Tyr Asn Lys 
1               5                   10                  15  


<210>  65
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:65

<400>  65

Pro Glu Ile Ile Leu Ser Lys Gly Tyr Asn Lys Ala Val Asp Trp 
1               5                   10                  15  


<210>  66
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:66

<400>  66

Leu Ser Lys Gly Tyr Asn Lys Ala Val Asp Trp Trp Ala Leu 
1               5                   10                  


<210>  67
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:67

<400>  67

Gly Tyr Asn Lys Ala Val Asp Trp Trp Ala Leu Gly Val Leu Ile 
1               5                   10                  15  


<210>  68
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:68

<400>  68

Ala Val Asp Trp Trp Ala Leu Gly Val Leu Ile Tyr Glu Met Ala 
1               5                   10                  15  


<210>  69
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:69

<400>  69

Trp Ala Leu Gly Val Leu Ile Tyr Glu Met Ala Ala Gly Tyr 
1               5                   10                  


<210>  70
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:70

<400>  70

Gly Val Leu Ile Tyr Glu Met Ala Ala Gly Tyr Pro Pro Phe Phe 
1               5                   10                  15  


<210>  71
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  Peptide_SEQ ID NO:71

<400>  71

Tyr Glu Met Ala Ala Gly Tyr Pro Pro Phe Phe Ala 
1               5                   10          


<210>  72
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:72

<400>  72

Glu Met Ala Ala Gly Tyr Pro Pro Phe Phe Ala Asp Gln Pro Ile 
1               5                   10                  15  


<210>  73
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:73

<400>  73

Gly Tyr Pro Pro Phe Phe Ala Asp Gln Pro Ile Gln Ile Tyr 
1               5                   10                  


<210>  74
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:74

<400>  74

Pro Phe Phe Ala Asp Gln Pro Ile Gln Ile Tyr Glu Lys Ile Val 
1               5                   10                  15  


<210>  75
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:75

<400>  75

Asp Gln Pro Ile Gln Ile Tyr Glu Lys Ile Val Ser Gly Lys Val 
1               5                   10                  15  


<210>  76
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:76

<400>  76

Ile Gln Ile Tyr Glu Lys Ile Val Ser Gly Lys Val Arg Phe 
1               5                   10                  


<210>  77
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:77

<400>  77

Tyr Glu Lys Ile Val Ser Gly Lys Val Arg Phe Pro Ser His Phe 
1               5                   10                  15  


<210>  78
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:78

<400>  78

Val Ser Gly Lys Val Arg Phe Pro Ser His Phe Ser Ser Asp Leu 
1               5                   10                  15  


<210>  79
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:79

<400>  79

Val Arg Phe Pro Ser His Phe Ser Ser Asp Leu Lys Asp Leu Leu 
1               5                   10                  15  


<210>  80
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:80

<400>  80

Ser His Phe Ser Ser Asp Leu Lys Asp Leu Leu Arg Asn Leu Leu 
1               5                   10                  15  


<210>  81
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:81

<400>  81

Ser Asp Leu Lys Asp Leu Leu Arg Asn Leu Leu Gln Val Asp Leu 
1               5                   10                  15  


<210>  82
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:82

<400>  82

Asp Leu Leu Arg Asn Leu Leu Gln Val Asp Leu Thr Lys Arg Phe 
1               5                   10                  15  


<210>  83
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:83

<400>  83

Asn Leu Leu Gln Val Asp Leu Thr Lys Arg Phe Gly Asn Leu Lys 
1               5                   10                  15  


<210>  84
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:84

<400>  84

Val Asp Leu Thr Lys Arg Phe Gly Asn Leu Lys Asn Gly Val 
1               5                   10                  


<210>  85
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:85

<400>  85

Thr Lys Arg Phe Gly Asn Leu Lys Asn Gly Val Asn Asp Ile Lys 
1               5                   10                  15  


<210>  86
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:86

<400>  86

Gly Asn Leu Lys Asn Gly Val Asn Asp Ile Lys Asn His Lys Trp 
1               5                   10                  15  


<210>  87
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  Peptide_SEQ ID NO:87

<400>  87

Asn Gly Val Asn Asp Ile Lys Asn His Lys Trp Phe Ala 
1               5                   10              


<210>  88
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:88

<400>  88

Val Asn Asp Ile Lys Asn His Lys Trp Phe Ala Thr Thr Asp Trp 
1               5                   10                  15  


<210>  89
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:89

<400>  89

Lys Asn His Lys Trp Phe Ala Thr Thr Asp Trp Ile Ala Ile Tyr 
1               5                   10                  15  


<210>  90
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:90

<400>  90

Trp Phe Ala Thr Thr Asp Trp Ile Ala Ile Tyr Gln Arg Lys Val 
1               5                   10                  15  


<210>  91
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:91

<400>  91

Thr Asp Trp Ile Ala Ile Tyr Gln Arg Lys Val Glu Ala Pro Phe 
1               5                   10                  15  


<210>  92
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:92

<400>  92

Ala Ile Tyr Gln Arg Lys Val Glu Ala Pro Phe Ile Pro Lys Phe 
1               5                   10                  15  


<210>  93
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  Peptide_SEQ ID NO:93

<400>  93

Arg Lys Val Glu Ala Pro Phe Ile Pro Lys Phe Lys 
1               5                   10          


<210>  94
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:94

<400>  94

Lys Val Glu Ala Pro Phe Ile Pro Lys Phe Lys Gly Pro Gly Asp 
1               5                   10                  15  


<210>  95
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:95

<400>  95

Pro Phe Ile Pro Lys Phe Lys Gly Pro Gly Asp Thr Ser Asn Phe 
1               5                   10                  15  


<210>  96
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:96

<400>  96

Lys Phe Lys Gly Pro Gly Asp Thr Ser Asn Phe Asp Asp Tyr 
1               5                   10                  


<210>  97
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  Peptide_SEQ ID NO:97

<400>  97

Gly Pro Gly Asp Thr Ser Asn Phe Asp Asp Tyr Glu Glu Glu Glu Ile 
1               5                   10                  15      


<210>  98
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:98

<400>  98

Ser Asn Phe Asp Asp Tyr Glu Glu Glu Glu Ile Arg Val Ser Ile 
1               5                   10                  15  


<210>  99
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:99

<400>  99

Asp Tyr Glu Glu Glu Glu Ile Arg Val Ser Ile Asn Glu Lys 
1               5                   10                  


<210>  100
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Peptide_SEQ ID NO:100

<400>  100

Glu Glu Glu Ile Arg Val Ser Ile Asn Glu Lys Cys Gly Lys 
1               5                   10                  


<210>  101
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  Peptide_SEQ ID NO:101

<400>  101

Ile Arg Val Ser Ile Asn Glu Lys Cys Gly Lys Glu Phe Ser Glu Phe 
1               5                   10                  15      


<210>  102
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Peptide_SEQ ID NO:102

<400>  102

Glu Asp Phe Leu Lys Lys Trp Glu Ser Pro Ala Gln Asn Thr Ala 
1               5                   10                  15  


<210>  103
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  Peptide_SEQ ID NO:103

<400>  103

Lys Lys Trp Glu Ser Pro Ala Gln Asn Thr Ala His Leu 
1               5                   10              


<210>  104
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  Peptide_SEQ ID NO:104

<400>  104

Ala Lys Arg Val Lys Gly Arg Thr Trp Thr Leu Cys Gly Arg Pro Glu 
1               5                   10                  15      


Ala 
    

<210>  105
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Orn, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is 4-chloro-L-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  Peptide_SEQ ID NO:105

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Orn

<400>  105

Xaa Arg Val Lys Gly Arg Thr Xaa Thr Leu Cys Gly Arg Pro Glu Xaa
1               5                   10                  15     


<210>  106
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Ala, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa is 4-chloro-L-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  Peptide_SEQ ID NO:106

<400>  106

Ala Lys Arg Val Lys Gly Arg Thr Xaa Thr Leu Cys Gly Arg Pro Glu Xaa
1               5                   10                  15


<210>  107
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Lys, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is 4-chloro-L-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  Peptide_SEQ ID NO:107

<400>  107


Lys Arg Val Lys Gly Arg Thr Xaa Thr Leu Cys Gly Arg Pro Glu Xaa
1               5                   10                  15     

<210>  108
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Lys, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  Peptide_SEQ ID NO:108

<400>  108

Lys Gly Arg Thr Xaa Thr Leu Cys
1               5              


<210>  109
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Val, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  Peptide_SEQ ID NO:109

<400>  109


Val Lys Gly Arg Thr Xaa Thr Leu Cys
1               5                  


<210>  110
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Val, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  Peptide_SEQ ID NO:110

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Orn

<400>  110


Val Xaa Gly Arg Thr Xaa Thr Leu Cys
1               5 


<210>  111
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Val, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  Peptide_SEQ ID NO:111


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Orn

<400>  111


Val Xaa Gly Arg Thr Xaa Thr Leu Cys Gly
1               5                   10 


<210>  112
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Val, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  Peptide_SEQ ID NO:112

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Orn

<400>  112


Val Xaa Gly Arg Thr Xaa Thr Leu Cys Gly Arg
1               5                   10


<210>  113
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Orn, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  4-chloro-L-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  Peptide_SEQ ID NO:113

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Orn

<400>  113


Xaa Gly Arg Thr Xaa Thr Leu Cys Xaa
1               5                   


<210>  114
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Orn, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  Peptide_SEQ ID NO:114

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Orn

<400>  114


Xaa Gly Arg Thr Xaa Thr Leu Cys 
1               5                               


<210>  115
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Lys, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  Peptide_SEQ ID NO:115

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Orn

<400>  115


Lys Val Xaa Gly Arg Thr Xaa Thr Leu Cys 
1               5                   10


<210>  116
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Lys, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  Peptide_SEQ ID NO:116

<400>  116


Lys Val Lys Gly Arg Thr Xaa Thr Leu Cys 
1               5                   10


<210>  117
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lipid modified Arg, e.g., Lauryl or Palmitoyl modified

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is 1-Naphthyl-L-alanine or 2-Naphthyl-L-alanine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  amine terminated

<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  Peptide_SEQ ID NO:117

<400>  117

Arg Val Lys Gly Arg Thr Xaa Thr Leu Cys 
1               5                   10


<210>  118
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  Peptide_SEQ ID NO:118

<400>  118

Lys Gly Arg Thr  
1              


<210>  119
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  Peptide_SEQ ID NO:119

<400>  119

Val Lys Gly Arg Thr  
1               5


<210>  120
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  Peptide_SEQ ID NO:120

<400>  120

Arg Val Lys Gly Arg Thr  
1               5


<210>  121
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  Peptide_SEQ ID NO:121

<400>  121

Lys Arg Val Lys Gly Arg Thr  
1               5


<210>  122
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  Peptide_SEQ ID NO:121

<400>  122

Xaa Arg Val Lys Gly Arg Thr  
1               5


<210>  123
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  Peptide_SEQ ID NO:123

<400>  123

Ala Lys Arg Val Lys Gly Arg Thr  
1               5
 

<210>  124
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  Peptide_SEQ ID NO:124

<400>  124

Thr Leu Cys Gly 
1

<210>  125
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  Peptide_SEQ ID NO:125

<400>  125

Thr Leu Cys Gly Arg 
1               5


<210>  126
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  Peptide_SEQ ID NO:126

<400>  126

Thr Leu Cys Gly Arg Pro Glu   
1               5


<210>  127
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  Peptide_SEQ ID NO:127

<400>  127

Thr Leu Cys Gly Arg Pro Glu Tyr   
1               5


<210>  128
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is 4-chloro-L-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  Peptide_SEQ ID NO:128

<400>  128

Thr Leu Cys Gly Arg Pro Glu Xaa   
1               5
